Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis

Background: Preliminary evidence for efficacy in pulmonary sarcoidosis has been shown for efzofitimod. Here we present supportive evidence of efficacy based on an exposure-response analysis. Methods: Data from two studies (Phase 1, N = 24, single dose in healthy volunteers, and Phase 1b/2a, N = 25,...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Gennyne, Adams, Ryan, Guy, Lauren, Chandrasekaran, Abhijeeth, Kinnersley, Nelson, Ramesh, Pavithra, Zhang, Lu, Brown, Fran, Niranjan, Vis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580085/
https://www.ncbi.nlm.nih.gov/pubmed/37854715
http://dx.doi.org/10.3389/fphar.2023.1258236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580085/
https://www.ncbi.nlm.nih.gov/pubmed/37854715
http://dx.doi.org/10.3389/fphar.2023.1258236

Ejemplares similares